Other News

Medtronic Receives FDA Approval for Implantable System for Remodulin® to Treat Patients with Pulmonary Arterial Hypertension

DUBLIN – July 31, 2018 – Medtronic plc (NYSE:MDT) has received U.S. Food and Drug Administration (FDA) approval for the Implantable System for Remodulin® (ISR) to treat patients with pulmonary arterial hypertension (PAH). Through a first-of-its-kind collaboration, the Medtronic SynchroMed(TM) II drug delivery system and cardiac catheter technologies were leveraged to […]

Semler Reports Second Quarter and First Half 2018 Financial Results

SAN JOSE, Calif., July 31, 2018 /PRNewswire/ — Semler Scientific, Inc. (OTCQB: SMLR), an emerging growth company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today reported financial results for the three and six months ended June 30, 2018. “We believe that the achievement of healthier clinical outcomes […]

Cardiovascular Systems, Inc. and Aerolase Corp. Sign Collaborative Agreement for Laser Atherectomy Technology

ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced that it has signed an agreement with Aerolase Corp. (Aerolase®) to co-develop a new laser atherectomy device for physicians to […]

FH Foundation Announces Consensus Statement on Genetic Testing for Familial Hypercholesterolemia (FH)

PASADENA, Calif., July 30, 2018 – The FH Foundation announced that an important consensus statement on diagnosing familial hypercholesterolemia (FH), a common life-threatening genetic condition, was published online today in the Journal of the American College of Cardiology. Authored by an international panel of 30 cardiovascular, lipid, genetics and advocacy experts and led by the FH […]

CARMAT Appoints Thierry Dupoux, Previously Worldwide Vice President of Quality Assurance at LivaNova, as Senior Director of Quality Assurance

PARIS–(BUSINESS WIRE)–Regulatory News: CARMAT (Paris:ALCAR) (FR0010907956, ALCAR), the designer and developer of the world’s most advanced total artificial heart project, aiming to provide a therapeutic alternative for people suffering from end-stage biventricular heart failure, today announced the appointment of Thierry Dupoux as Senior Director of Quality Assurance. Thierry Dupoux is […]

Tenaya Therapeutics Appoints Faraz Ali as Chief Executive Officer

SOUTH SAN FRANCISCO, Calif., July 30, 2018 /PRNewswire/ — Tenaya Therapeutics, a preclinical-stage biotechnology company focused on discovery and development of novel therapies for heart failure, announced the appointment of Faraz Ali as Chief Executive Officer. “We are thrilled to bring Faraz on board as the new CEO,” said David Goeddel, Ph.D., Managing Partner at The […]

Stem Cell Therapies in CVMD

LONDON, July 30, 2018 /PRNewswire/ — Stem Cell Therapies in CVMDSummaryRegenerative medicine could potentially cure diseases and may replace palliative treatments for chronic diseases.Stem cells in particular have been studied for their regenerative properties: their potential to repair or replace damaged or diseased human cells or tissues to restore normal function.Download the full […]

TransMed7, LLC Announces Appointment of Dr. John Simpson as Strategic Advisor to Its Board of Directors

PORTOLA VALLEY, Calif.–(BUSINESS WIRE)–TransMed7, LLC is delighted to announce the appointment of John B. Simpson, Ph.D., M.D., as Strategic Advisor to the TransMed7 Board of Directors. “Dr. Simpson’s remarkable history of clinical excellence, innovation, scientific achievement, and entrepreneurial expertise immediately expands TransMed7’s strategic options for rapid development and deployment of […]

LeMaitre Q2 2018 Record Sales $27.0mm (+5%), Record EPS $0.43 (+86%)

BURLINGTON, Mass., July 26, 2018 (GLOBE NEWSWIRE) — LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q2 2018 results, provided guidance and announced a $0.07/share dividend. Q2 2018 Results Record sales of $27.0mm, +5% vs. Q2 2017 Record operating income of $11.5mm vs. $5.5mm, +108% Record net income […]